Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.
Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.
复制标题
DOI:
10.1161/circulationaha.108.791533
复制
发表时间:
2008-11-04
期刊:
影响因子:
37.8
通讯作者:
Bhatnagar A
中科院分区:
文献类型:
--
作者:
West MB;Rokosh G;Obal D;Velayutham M;Xuan YT;Hill BG;Keith RJ;Schrader J;Guo Y;Conklin DJ;Prabhu SD;Zweier JL;Bolli R;Bhatnagar A
Inducible nitric oxide synthase (iNOS) is an obligatory mediator of the late phase of ischemic preconditioning (PC) but the mechanisms of its cardioprotective actions are unknown. In addition, it remains unclear whether sustained elevation of iNOS in myocytes provides chronic protection against ischemia-reperfusion injury. Constitutive overexpression of iNOS in transgenic (TG) mice (α-myosin heavy chain promoter) did not induce contractile dysfunction and did not affect mitochondrial respiration or biogenesis, but profoundly decreased infarct size in mice subjected to 30 min of coronary occlusion and 24 h of reperfusion. In comparison with wild-type (WT) hearts, isolated iNOS-transgenic (TG) hearts subjected to ischemia for 30 min followed by 40 min of reperfusion displayed better contractile recovery, smaller infarct size, and less mitochondrial entrapment of 2-deoxy-[3H]-glucose (DOG). Reperfusion-induced loss of NAD+ and mitochondrial release of cytochrome c were attenuated in iNOS-TG hearts, indicating reduced mitochondrial permeability transition (MPT). The NO donor NOC-22 prevented permeability transition in isolated mitochondria, and MPT-induced NAD+ loss was decreased in WT but not iNOS-null mice treated with the NO donor DETA/NO, 24 h before ischemia and reperfusion ex vivo. iNOS-mediated cardioprotection was not abolished by atractyloside. Reperfusion-induced production of oxygen-derived free radicals (measured by electron paramagnetic resonance spectroscopy) was attenuated in iNOS-TG hearts and was increased in WT hearts treated with the MPT inhibitor cyclosporin A. Cardiomyocyte-restricted expression of iNOS provides sustained cardioprotection. This is associated with a decrease in reperfusion-induced oxygen radicals and inhibition of mitochondrial swelling and permeability transition.